Short-interval intracortical inhibition in Parkinson’s disease using anterior-posterior directed currents

2011 ◽  
Vol 214 (2) ◽  
pp. 317-321 ◽  
Author(s):  
R. Hanajima ◽  
Y. Terao ◽  
Y. Shirota ◽  
S. Ohminami ◽  
S. Nakatani-Enomoto ◽  
...  
2013 ◽  
Vol 124 (8) ◽  
pp. e36
Author(s):  
Yuichiro Shirota ◽  
Yasuo Terao ◽  
Shinya Ohminami ◽  
Ryosuke Tsutsumi ◽  
Yoshikazu Ugawa ◽  
...  

Brain ◽  
2020 ◽  
Vol 143 (11) ◽  
pp. 3408-3421 ◽  
Author(s):  
Claudia Ammann ◽  
Michele Dileone ◽  
Cristina Pagge ◽  
Valentina Catanzaro ◽  
David Mata-Marín ◽  
...  

Abstract In Parkinson’s disease, striatal dopamine depletion produces profound alterations in the neural activity of the cortico-basal ganglia motor loop, leading to dysfunctional motor output and parkinsonism. A key regulator of motor output is the balance between excitation and inhibition in the primary motor cortex, which can be assessed in humans with transcranial magnetic stimulation techniques. Despite decades of research, the functional state of cortical inhibition in Parkinson’s disease remains uncertain. Towards resolving this issue, we applied paired-pulse transcranial magnetic stimulation protocols in 166 patients with Parkinson’s disease (57 levodopa-naïve, 50 non-dyskinetic, 59 dyskinetic) and 40 healthy controls (age-matched with the levodopa-naïve group). All patients were studied OFF medication. All analyses were performed with fully automatic procedures to avoid confirmation bias, and we systematically considered and excluded several potential confounding factors such as age, gender, resting motor threshold, EMG background activity and amplitude of the motor evoked potential elicited by the single-pulse test stimuli. Our results show that short-interval intracortical inhibition is decreased in Parkinson’s disease compared to controls. This reduction of intracortical inhibition was obtained with relatively low-intensity conditioning stimuli (80% of the resting motor threshold) and was not associated with any significant increase in short-interval intracortical facilitation or intracortical facilitation with the same low-intensity conditioning stimuli, supporting the involvement of cortical inhibitory circuits. Short-interval intracortical inhibition was similarly reduced in levodopa-naïve, non-dyskinetic and dyskinetic patients. Importantly, intracortical inhibition was reduced compared to control subjects also on the less affected side (n = 145), even in de novo drug-naïve patients in whom the less affected side was minimally symptomatic (lateralized Unified Parkinson’s Disease Rating Scale part III = 0 or 1, n = 23). These results suggest that cortical disinhibition is a very early, possibly prodromal feature of Parkinson’s disease.


2016 ◽  
Vol 127 (4) ◽  
pp. 2031-2037 ◽  
Author(s):  
Masahito Kobayashi ◽  
Takayuki Ohira ◽  
Ban Mihara ◽  
Takamitsu Fujimaki

2012 ◽  
Vol 19 (3) ◽  
pp. 161-166
Author(s):  
Mônica Del Rosario Sánchez-Arias ◽  
Ana Francisca Rozin Kleiner ◽  
Ágata Yoko Yasue Hamanaka ◽  
Paulo Roberto Pereira Santiago ◽  
Lilian Teresa Bucken Gobbi ◽  
...  

2018 ◽  
Vol 6 (3) ◽  
pp. 447 ◽  
Author(s):  
Rowena K Merritt ◽  
Sarah Hotham ◽  
Lizzie Graham ◽  
Anette Schrag

Objective: To describe the experience of being diagnosed and living with mild to moderate Parkinson’s disease (PD).Method: Semi-structured in-depth interviews with people with Parkinson’s (PwP) in 11 European countries.Results: Interviews with 60 PwP (52% male) with a mean age of 63 (SD 8.1) years and a disease duration of 9.6 (SD 6.9) years were analysed. PwP often delayed help-seeking due to lack of awareness of symptoms and there was sometimes a delay in specialist referral. The diagnosis typically came as a “shock”, making PwP unable to absorb all the information, but having a diagnosis for the symptoms was sometimes described as a “relief”. Prompt referral to a specialist, a clear and sensitively communicated diagnosis with reassurance about prognosis and a follow-up appointment with a PD nurse or other healthcare professionals a short interval after diagnosis were all positively viewed. Many reported worries and negative experiences with medications and wished for more time and information before initiating these. Reactions from family, friends and work colleagues when communicating the diagnosis were typically positive. During ongoing care, longer appointments with specialists and provision of information from healthcare professionals, patient organisations and self-help groups were considered important to many PwPs and helped them feel as if they could “take control” and manage their disease more effectively.Conclusions: Taking into account these findings has the potential to improve the experiences of PwP through improved communication, tailoring of appointments and information provision including self-help approaches.


Author(s):  
Alfredo Berardelli ◽  
Mark Hallett

Transcranial magnetic stimulation (TMS) is applied to study patients with movement disorders. This article reviews the findings of such applications in patients with Parkinson's disease, dystonia, Huntington's disease, Tourette's syndrome, and essential tremor. The findings related to Parkinson's disease are characterized by a shortening of the cortical silence period (cSP), a reduction of short intracortical inhibition, an increase in the long-lasting intracortical inhibition, and a reduction of the normal motor evoked potential facilitation after single and repetitive TMS stimuli. Studies with paired-pulse TMS have provided controversial information on cortical motor excitability in Huntington's disease. The findings in dystonia include: a reduction of the short intracortical inhibition and a shortening of the cSP. In Tourette's syndrome patients, the cSP is short and intracortical inhibition is decreased. Patients with essential tremor have normal corticospinal conduction, normal duration of the cSP, and normal intracortical inhibition. Such application of TMS has produced enormous data and continues to do so.


Sign in / Sign up

Export Citation Format

Share Document